Summary
A potent lupus anticoagulant (LA) was detected in four children, 1 week after the clinical onset of an adenovirus infection. The adenovirus infection was documented by direct virus detection in the stool of one patient and serologically in the others. None of the children had elevated titers of IgM- and only one of IgG-anticardiolipin antibodies (ACA). All patients had a marked reduction of prothrombin activity as well as antigen. Prothrombin-antibody complexes were demonstrated in the patients' plasma or mixtures of patient and normal plasma. Factor XII activity was moderately reduced in three of the patients. All coagulation abnormalities returned to normal within 4–12 weeks. Localized bleeding was observed in two cases, but there was no generalized bleeding tendency or evidence of thrombosis.
Similar content being viewed by others
References
Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB (1983) A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 61:684–692
Beck DW, Strauss RG, Kisker T, Henriksen RA (1979) An intrinsic coagulation pathway inhibitor in a 3-year-old child. Am J Clin Pathol 71:470
Boxer M, Ellman L, Carvalho A (1976) The lupus anticoagulant. Arthritis Rheum 19:1244–1248
Brodeur GM, O'Neill PJ, Williams JA (1980) Acquired inhibitors of coagulation in nonhemophilic children. J Pediatr 96:439
Colaco CB, Mackie IL, Irving W, Machin SJ (1989) Anti-cardiolipin antibodies in viral infection. Lancet 18:622
Edson JR, Vogt JM, Hasegawa DK (1984) Anbnormal prothrombin crossed-immunoelectrohoresis in patients with lupus inhibitors. Blood 64:807–816
Feinstein DI (1991) Acquired inhibitors of blood coagulation. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ (eds) Hematology-basic principles and practice, 1st edn. Churchill Livingstone, New York, pp 1385–1394
Fleck RA, Rapaport SI, Rao LVM (1988) Anti-prothrombin antibodies and the lupus anticoagulant. Blood 72:512–519
Kapiotis S, Speiser W, Pabinger-Fasching I, Kyrle PA, Lechner K (1991) Anticardiolipin antibodies in patients with venous thrombosis. Haemostasis 21:19–24
Lechner K (1969) A new type of coagulation inhibitor. Thromb Diath Haemorrh 21:442–449
Lechner K (1974) Acquired inhibitors in non-hemophilic patients. Haemostasis 3:65–93
Lechner K, Pabinger-Fasching I (1985) Lupus anticoagulants and thrombosis. Haemostasis 15:254–262
Pabinger-Fasching I, Bertina RM, Lechner K, Niessner H, Korninger C (1983) Protein C deficiency in two Austrian families. Thromb Haemost 50:810–813
Rauch J, Tannenbaum M, Janoff AS (1989) Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 62:892–896
Roisin JP, Contant G, Martinoli JL (1991) Detection of lupus-like anticoagulants (LA). Use of hexagonal phosphatidylethanolamine and of an APTT reagent sensitive to LA. Throm Haemost 65:1255
Rugman FP, Pinn G, Palmer MF, Waite M, Hay CR (1991) Anticardiolipin antibodies in leptospirosis. J Clin Patheol 44:517–519
Schleider MA, Nachman RL, Jaffe EA, Colaman M (1976) A clinical study of the lupus anticoagulant. Blood 48:499–509
Thiagarajan P, Shapiro SS, De Marco L (1980) Monoclonal immunoglobulin M-gamma coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant. J Clin Invest 66:397–405
Triplett DA, Brandt JT, Musgrave KA, Orr CA (1988) The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 259:550–554
Wright PF (1992) Adenoviruses. In: Kelly WN (ed) Textbook of internal medicine, 2nd edn. Lippincott, Philadelphia, p 1481
Yamazaki M, Asakura H, Kawamura Y, Ohka T, Endo M, Matsuda T (1991) Transient lupus anticoagulant induced by Epstein-Barr virus infection. Blood Coagul Fibrinolysis 2:771–774
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jaeger, U., Kapiotis, S., Pabinger, I. et al. Transient lupus anticoagulant associated with hypoprothrombinemia and Factor XII deficiency following adenovirus infection. Ann Hematol 67, 95–99 (1993). https://doi.org/10.1007/BF01788133
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01788133